Senti Biosciences, Inc. (SNTI)
NASDAQ: SNTI · Real-Time Price · USD
2.130
-0.090 (-4.05%)
At close: Dec 5, 2025, 4:00 PM EST
2.240
+0.110 (5.16%)
After-hours: Dec 5, 2025, 7:47 PM EST
Senti Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -47.58 | -52.79 | -71.06 | -58.21 | -55.32 | -19.86 | |
| Depreciation & Amortization | 5.69 | 5.85 | 5.43 | 3.92 | 3.01 | 1.99 | |
| Loss (Gain) From Sale of Assets | -0.11 | - | -21.86 | - | - | - | |
| Asset Writedown & Restructuring Costs | - | 0.31 | 25.96 | - | 0.02 | 0.24 | |
| Loss (Gain) From Sale of Investments | - | - | -1.07 | -0.36 | - | -0 | |
| Stock-Based Compensation | 4.89 | 1.76 | 9.67 | 16.39 | 2.3 | 0.27 | |
| Other Operating Activities | -13.26 | -0.57 | -4.13 | -10.55 | 14.74 | -5.03 | |
| Change in Accounts Receivable | -0.57 | -0.73 | -0.93 | -0.13 | -0.4 | -0.01 | |
| Change in Accounts Payable | 1.81 | 0.8 | -0.29 | 0.19 | -0.62 | -0.32 | |
| Change in Unearned Revenue | -0.64 | -0.33 | -0.11 | -1.03 | 1.83 | 0.17 | |
| Change in Other Net Operating Assets | -0.3 | 4.3 | 5.99 | 14.88 | -0.21 | -1.61 | |
| Operating Cash Flow | -50.07 | -41.4 | -52.4 | -34.9 | -34.64 | -24.17 | |
| Capital Expenditures | -0.21 | -0.03 | -12.04 | -41.37 | -5.54 | -1.16 | |
| Sale of Property, Plant & Equipment | 0.01 | 0.06 | 0.11 | - | - | - | |
| Investment in Securities | - | - | 42.01 | -40.59 | - | 12.52 | |
| Investing Cash Flow | -0.2 | 0.03 | 30.08 | -81.96 | -5.54 | 11.36 | |
| Short-Term Debt Issued | - | - | - | - | - | 8 | |
| Long-Term Debt Issued | - | - | - | 117.15 | - | - | |
| Total Debt Issued | - | - | - | 117.15 | - | 8 | |
| Long-Term Debt Repaid | - | - | -0.11 | - | -0.02 | - | |
| Net Debt Issued (Repaid) | - | - | -0.11 | 117.15 | -0.02 | 8 | |
| Issuance of Common Stock | 49.72 | 49.06 | 0.89 | 1.4 | 1.5 | 0.33 | |
| Other Financing Activities | 2.29 | 4.67 | - | - | - | -0.28 | |
| Financing Cash Flow | 52.01 | 53.73 | 0.78 | 118.55 | 68.44 | 38.05 | |
| Net Cash Flow | 1.74 | 12.37 | -21.54 | 1.7 | 28.26 | 25.24 | |
| Free Cash Flow | -50.28 | -41.42 | -64.43 | -76.27 | -40.18 | -25.33 | |
| Free Cash Flow Margin | - | - | -2515.93% | -1779.51% | -1455.20% | -4475.97% | |
| Free Cash Flow Per Share | -2.99 | -9.01 | -14.52 | -29.21 | -137.96 | -18.27 | |
| Levered Free Cash Flow | -23.48 | -1.61 | -75.14 | -57.23 | -17.92 | -14.27 | |
| Unlevered Free Cash Flow | -23.48 | -1.61 | -75.14 | -57.23 | -17.92 | -14.27 | |
| Change in Working Capital | 0.3 | 4.04 | 4.67 | 13.9 | 0.62 | -1.78 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.